# HB 642: Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

90th Legislature (90R) · House · Status: Filed

Record current as of: the Legislative Council last updated this bill's record 11/11/2026 2:00:22 AM; this site copied it 2026-11-21T22:18:17.720605Z.

How to read this page: **Official record** is copied unchanged from the Texas Legislative Council's bill files, the data behind Texas Legislature Online. **Computed by this site** is worked out by fixed rules from that record. **AI analysis (Luna)** is written by an AI model that read the bill text; it can be wrong, so check it against the bill text.

## Official record

Source: Texas Legislative Council bill files (ftp.legis.state.tx.us), copied unchanged.

- Filed: 2026-11-09
- Most recent action: 2026-11-09 · House: Filed
- Official subjects (Legislative Council index): Health--Other Diseases & Medical Conditions; Insurance--Health & Accident; MEDICINE & PRESCRIPTION DRUGS
- Companion bills: none listed in the source data

### Caption

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

### Bill text

The official wording of each version, copied from the Texas Legislative Council's bill text files and converted to Markdown with the wording unchanged. Language the bill adds is marked <ins>like this</ins>; language it removes is in [<del>brackets</del>]. To check a copy, fetch the official file and compare its SHA-256 with the one listed; the copy's own SHA-256 confirms you received it unaltered.

- Introduced: https://billatlas.org/live/text/HB642/I.md
  - Official file: ftp://ftp.legis.state.tx.us/bills/90R/billtext/HTML/house_bills/HB00600_HB00699/HB00642I.HTM, last modified 2026-11-09 19:08:50 UTC, SHA-256 69f3c4056c878172cd3371bff22d540ea58969b12cc002acc86852b89e03be5b
  - This copy: made 2026-11-11T08:27:07.698538Z, SHA-256 of the Markdown 30e346d596023e66af5eb36991d690f04af5bbb59cbbca040108de5c84418491

#### Text of the latest version (Introduced)

````markdown
# HB 642 - Introduced

90R3268 DNC-D

By: Jones of Dallas H.B. No. 642

A BILL TO BE ENTITLED

AN ACT

relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

### SECTION 1.

The heading to Subchapter N, Chapter 1369, Insurance Code, is amended to read as follows: SUBCHAPTER N. COVERAGE OF PRESCRIPTION DRUGS FOR AUTOIMMUNE <ins>AND NEURODEGENERATIVE</ins> DISEASES AND CERTAIN BLOOD DISORDERS

### SECTION 2.

Section 1369.654, Insurance Code, is amended by amending Subsection (a) and adding Subsection (c) to read as follows:

(a) A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat an autoimmune disease, <ins>a neurodegenerative disease,</ins> hemophilia, or Von Willebrand disease.

<ins>(c) Notwithstanding Subsection (a), a health benefit plan issuer may require an enrollee who is prescribed a new prescription drug to treat a neurodegenerative disease to obtain a prior authorization for the prescription drug.</ins>

### SECTION 3.

The change in law made by this Act applies only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2028. A health benefit plan delivered, issued for delivery, or renewed before January 1, 2028, is governed by the law as it existed immediately before the effective date of this Act, and that law is continued in effect for that purpose.

### SECTION 4.

This Act takes effect September 1, 2027.
````

### Current law this bill changes

Each section as it stands now, from this site's copy of the Texas Legislative Council's statute files (wording unchanged); the official page is the authority. Sections are matched automatically from the bill text and can be missed, for example when a bill changes a whole chapter at once.

- Insurance Code §1369.654 (amended): Sec. 1369.654. PROHIBITION ON MULTIPLE PRIOR AUTHORIZATIONS.
  - This copy (whole chapter): https://billatlas.org/live/law/IN/1369.md, copied 2026-11-21T02:14:24.675852+00:00, SHA-256 of the Markdown f8785bcfb6622020cf6b6c725e13561e4f665ce024528ad37c8c09f7087953ea
  - Official: https://statutes.capitol.texas.gov/Docs/IN/htm/IN.1369.htm

````markdown
Sec. 1369.654. PROHIBITION ON MULTIPLE PRIOR AUTHORIZATIONS. (a) A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat an autoimmune disease, hemophilia, or Von Willebrand disease.

(b) This section does not apply to:

(1) opioids, benzodiazepines, barbiturates, or carisoprodol;

(2) prescription drugs that have a typical treatment period of less than 12 months;

(3) drugs that:

(A) have a boxed warning assigned by the United States Food and Drug Administration for use; and

(B) must have specific provider assessment; or

(4) the use of a drug approved for use by the United States Food and Drug Administration in a manner other than the approved use.

Added by Acts 2023, 88th Leg., R.S., Ch. 669 (H.B. 755), Sec. 1, eff. September 1, 2023.

SUBCHAPTER Q. CLINICIAN-ADMINISTERED DRUGS
````


### Authors and sponsors

Authors and coauthors serve in the originating chamber; sponsors and cosponsors in the other chamber. Authorship does not indicate a vote or caucus position.

#### Authors

- Venton Jones (Democratic · HD 100 · 4 years served · since 2023) · [bills](https://agent.billatlas.org/authors/house-jones-venton.md)

_No coauthors, sponsors or cosponsors listed: no bill in this snapshot lists any yet, so this reflects the stage of the source data, not this bill._

### Recorded actions

1. 2026-11-09: Filed

## Computed by this site

Worked out by fixed rules from the official record above; not a statement by the Legislature.

- Status: Filed
- Most recent action type: Filed
- Hearing status: No hearing yet. No committee referral or hearing has been verified. A likelihood estimate would be premature.
- Authorship: Democratic author. Authors: 1 Democratic
- Author prominence: Mid-tenure author. 4 years in the House

## AI analysis (Luna)

Written by Luna, an AI model that reads the full bill text. It can be wrong; the bill text above is the authority. Tags marked caption-rules come from keyword rules applied to the caption, not from the AI.

### Summary

Reviewed 2026-11-13T23:57:51Z · introduced text. Fields from the full text: topics, agencies, impacts, constituencies, locations; other fields use caption inference.

The bill extends the annual limit on prior authorizations for prescription drug benefits to drugs prescribed for neurodegenerative diseases, while allowing an issuer to require prior authorization when an enrollee is prescribed a new drug for such a disease. The change applies to health benefit plans delivered, issued for delivery, or renewed on or after January 1, 2028.

### Topics

- Healthcare

### Potentially affected agencies

Possible links are rule or model inferences, not confirmed legal obligations.

_The full-text review tagged no state agency. This does not establish that none are affected._

### Types of impact

- Prior-authorization limit with new-drug exception

### People and institutions affected

- Enrollees prescribed drugs to treat neurodegenerative diseases
- Health benefit plan issuers

### Locations

- Statewide (statewide): The changes amend the Texas Insurance Code and apply to covered health benefit plans without a narrower geographic limitation.

## Links

- Full bill text (official wording, Markdown): https://billatlas.org/live/text/HB642/I.md
- Official bill history: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=90R&Bill=HB642
- Official bill text (every version, HTML/PDF/Word): https://capitol.texas.gov/BillLookup/Text.aspx?LegSess=90R&Bill=HB642
- Open in the tracker: https://billatlas.org/bill/HB642
- RSS feed of actions: https://billatlas.org/live/feeds/HB642.xml
- This page as JSON: https://agent.billatlas.org/bills/HB642.json
- Search all bills: https://agent.billatlas.org/search?q= followed by your words, e.g. https://agent.billatlas.org/search?q=Healthcare

---
Unofficial, independent open-source project; not a state website. The official record and bill text on this page are copied unchanged from the Texas Legislative Council bill files, refreshed hourly, so they can trail the Legislature by up to an hour or two. Computed fields and the AI analysis can be wrong. Not legal advice. For anything that matters, confirm on Texas Legislature Online.
